[#2021Highlights] What happened in 2021🎉? Check out the highlight #🔟 👇 #WeAreServier #WeWontRest Find out more information on servier.com
We are pleased to announce that we have joined Act4Nature International, an initiative for voluntary commitment to biodiversity 🌳. As Vincent Minvielle, CSR Director of Servier Group, stated: 🗣️ “By joining Act4Nature, we reaffirm Servier Group’s commitment to biodiversity with specific actions that respond to the challenges facing the planet.” We are implementing different actions in favor of biodiversity, such as reducing the environmental impact of our industrial chemical synthesis, through the deployment of “Green Score”, an internal evaluation tool. Check out more 👉 https://bit.ly/3DaQf8O #Act4Nature #biodiversity #csr
We were pleased to invite institutions and media to visit the construction site 🚧 of our new production unit on our production site #OrilIndustrie in France This new production unit will reinforce our production of the active ingredient used in one of our medicines 💊, while reducing our impact on the environment 🌳. Today, #OrilIndustrie produces 98% of the active ingredients, which are shipped mainly to our 9 pharmaceutical production sites for brand-name medicines prescribed mainly in the fields of cardiology, neurosciences, and diabetes. Check out more about this new production unit 👉 https://bit.ly/3l7YqfW #industry
🗣️ “The collaborative environment, empowerment, recognition, and rewards –these are just few of the many things I like with my job.” Oliver Dacillo, Sales and Marketing Director in the #ServierPhilippines subsidiary talks about our HR practices and our commitment to being a great place to work. 💪 Creating the right conditions for our employees to thrive is our priority. #GlobalTopEmployer #GPTW #WeAreServier
Hypertension! A disease that we can fight by working alongside health care professionals 👩⚕️🧑⚕️ to remind the people around us to take their medicine 💊! 🗣️ Listen to Pr Poulter, Past President of the International Society of Hypertension International Society of Hypertension explaining why #adherence is an important issue #TakeYourMedicine #BecauseIsayso #adherence #hypertension #highcholesterol
Adherence to treatment 💊in hypertension: how patients, doctors, and companies can join forces to improve it. 📽️👇Watch the webinar with Pr Burnier, Pr Poulter, and Pr Johnson. #TakeYourMedicine #BecauseIsayso #adherence #hypertension #highcholesterol
📢 Let’s Volunteer by Mécénat Servier is now online! 👨💻👩💻 volunteer.servier.com The platform allows our partner associations and Group employees to get involved in all the schemes offered by Mécénat Servier 🔥🚀. Let’s Volunteer is also a way to showcase 👨💻👩💻 all Mécénat Servier’s activities. 📱 Discover all the news, publications, and key data regarding the Charity Fund, as well as an introduction to the various partner associations 👉volunteer.servier.com
[#ESCCcongress] The ESC Congress is nearly here! We’re attending the annual meeting of the ESC Congress organized by of the European Society of Cardiology. 🗓️ 27 - 30 August Visit our company page and take part in our 4 symposia and our 12 tutorials.
Anti-PD-1 and anti-PD-L1 immunotherapies are innovative and promising treatments in the fight against certain types of cancer. What is their mode of action? The immunotherapy aims to lift the immune brake that the tumor cell exerts on the immune system. In concrete terms, it involves injecting antibodies which will attach to the tumor cell (PD-L1) and T cells (PD-1). This blocks the binding between PD-1 and PD-L1 and consequently allows the immune system to return to its initial function and fight the disease.
[#ParisSaclay] "The Servier Research and Development Institute at Paris-Saclay is an unique opportunity for us to rethink our R&D, our way of working and also to be open to the outside world. This Paris-Saclay campus is a place of exchange and collective intelligence, serving new therapeutic solutions for patients." Christophe Thurieau, Executive Director of Servier Research Check out his interview 👇
